Bellicum Pharmaceuticals Inc. News
Why 2018 will be better for biotech deals than 2017
Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.
Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMI
Here's what you need to know now for Monday, Jan. 22.
Immunotherapy stocks power higher on Celgene-Juno deal
Shares of immunotherapy companies including Ziopharm Oncology and Fate Therapeutics rose early on Monday on the heels of Juno Therapeutics' announced sale to Celgene.
Elliott Notches Win at Advisory Board, Monitors Progress with NRG - ICYMI
Here's what you need to know now for Tuesday, August 29.
Biotech Movers: Ironwood Shares Jump On FDA Approval for Hyperuricemia Drug
The Cambridge, Mass.-based firm clinched FDA approval for hyperuricemia drug Duzallo.
Biotech Movers: Global Blood Shares Rise on PRIME Designation
Global Blood Therapeutics, Kite Pharma and Bellicum Pharmaceuticals were among the biotech movers in premarket trading on June 28.
Why Gilead Sciences Is Nearing Yet Another Mind-Bending Breakout
The stock has been on fire.
Cisco Systems Stock Leaps On Q4 Earnings Beat, 2023 Sales Outlook As Supply Chain Pressures Ease
"Overall supply constraints began to ease slightly at the back half of the fourth quarter and continuing into the start of the first quarter," said CEO Chuck Robbins.
Ransomware Suspect Charged in U.S. as Incidents Surge
A Russian citizen is charged in the U.S. for his alleged role in an international cryptocurrency money laundering conspiracy.
TheStreet's Doug Kass: Don't Be Fooled by Stock Rally
The S&P 500 index has jumped 11% in the past month, 'reducing the general attraction of equities,' investor Doug Kass says.